Metraipolis › archive › dc_01d0ea984140
Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III… — Europe PMC PMID:42630515
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42630515
- DOI
- 10.1016/j.jncc.2026.04.002
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T14:10:40.371Z
- SHA-256 of the archived text
265f0a5ac5b1f39b9dc48ab136053be468a7b59c9eccb3c0656144951079aae8- Stable URL of this page
https://metraipolis.com/documento/dc_01d0ea984140
How to cite
Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III… — Europe PMC PMID:42630515 — Europe PMC (en), https://europepmc.org/article/MED/42630515 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_01d0ea984140 (Metraipolis archive dc_01d0ea984140, sha256 265f0a5ac5b1f39b9dc48ab136053be468a7b59c9eccb3c0656144951079aae8)
BibTeX
@misc{dc01d0ea984140,
title = {Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III… — Europe PMC PMID:42630515},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42630515},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_01d0ea984140; sha256 265f0a5ac5b1f39b9dc48ab136053be468a7b59c9eccb3c0656144951079aae8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42630515. Agents can read the archived copy with the MCP tool read_document.